Integrating multiomics to elucidate the role of chromatin remodeling in glioma and the antitumor mechanisms and therapeutic potential of targeting LMNA - Scorecard - MDSpire

Integrating multiomics to elucidate the role of chromatin remodeling in glioma and the antitumor mechanisms and therapeutic potential of targeting LMNA

  • By

  • Kun Wang

  • Feini Xu

  • Lingjie Zhu

  • Jiaying Wang

  • Haibo Li

  • Xianwen Cao

  • Xuhan Wang

  • Da Zong

  • Yuankun Liu

  • Junfei Shao

  • May 8, 2026

  • 0 min

Share

Clinical Scorecard: Utilizing Multiomics to Investigate Chromatin Remodeling's Impact on Glioma and the Therapeutic Potential of Targeting LMNA in Antitumor Strategies

At a Glance

CategoryDetail
ConditionGlioma
Key MechanismsChromatin remodeling and its impact on tumorigenesis.
Target PopulationAdults with glioma, including low-grade gliomas (LGGs) and glioblastoma (GBM).
Care SettingOncology and neurology departments.

Key Highlights

  • Identified 28 glioma-specific chromatin remodeling-related genes (CRRGs).
  • Developed a prognostic signature for risk stratification in glioma patients.
  • LMNA was identified as a potential prognostic biomarker and therapeutic target.
  • In vitro and in vivo studies demonstrated that LMNA depletion impairs tumor growth.
  • Four natural compounds were identified as candidate LMNA inhibitors.

Guideline-Based Recommendations

Diagnosis

  • Utilize RNA-seq profiles for identifying CRRGs in glioma.

Management

  • Consider targeting LMNA in therapeutic strategies for glioma.

Monitoring & Follow-up

  • Implement the CRRG-based prognostic signature for patient stratification.

Risks

  • Recognize the aggressive nature of gliomas and their resistance to standard therapies.

Patient & Prescribing Data

Patients diagnosed with glioma, particularly those with poor prognostic indicators.

Targeting LMNA may provide a novel therapeutic approach in glioma management.

Clinical Best Practices

  • Integrate multi-omics data for comprehensive profiling of glioma.
  • Employ machine-learning frameworks for prognostic model development.
  • Validate findings through in vitro and in vivo experimental assays.

References

Original Source(s)

Integrating multiomics to elucidate the role of chromatin remodeling in glioma and the antitumor mechanisms and therapeutic potential of targeting LMNA

  • by Kun Wang, Feini Xu, Lingjie Zhu, Jiaying Wang, Haibo Li, Xianwen Cao, Xuhan Wang, Da Zong, Yuankun Liu, Junfei Shao

  • May 8, 2026

Related Content

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study